Angioedema News and Research

RSS
Angioedema is the rapid swelling (edema) of the dermis, subcutaneous tissue, mucosa and submucosal tissues. It is very similar to urticaria, but urticaria, commonly known as hives, occurs in the upper dermis.
Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

Health Canada approves first post-surgical treatment for patients with gastrointestinal stromal tumours

FDA grants orphan drug exclusivity approval for Octapharma AG's wilate

FDA grants orphan drug exclusivity approval for Octapharma AG's wilate

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

ViroPharma signs agreement with Sanquin Blood Supply Foundation to develop and commercialize Cinryze

RMEI and PIM sponsor medical education virtual lecture for physicians on HAE management

RMEI and PIM sponsor medical education virtual lecture for physicians on HAE management

Physicians need to utilize best practices to treat HAE patients in emergency settings

Physicians need to utilize best practices to treat HAE patients in emergency settings

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Tasigna demonstrates greater efficacy over Gleevec in chronic Ph+ CML patients

Pharming Group NV's pre-BLA meeting with the FDA for Rhucin

Pharming Group NV's pre-BLA meeting with the FDA for Rhucin

CSL Behring selects BioRx as an approved Berinert provider

CSL Behring selects BioRx as an approved Berinert provider

RCT licensee Dyax receives approval from the FDA for KALBITOR

RCT licensee Dyax receives approval from the FDA for KALBITOR

Kalbitor drug approved by FDA

Kalbitor drug approved by FDA

New data demonstrating the strength of Novartis' hematology portfolio to be presented

New data demonstrating the strength of Novartis' hematology portfolio to be presented

FDA grants approval for Dyax' KALBITOR for treating HAE patients

FDA grants approval for Dyax' KALBITOR for treating HAE patients

Tibotec Therapeutics'  INTELENCE granted FDA traditional approval

Tibotec Therapeutics' INTELENCE granted FDA traditional approval

FDA approves Berinert for treating HAE in adults and adolescents

FDA approves Berinert for treating HAE in adults and adolescents

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

U.S. Court rules in Merck's favor in Flemings case involving FOSAMAX

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

New data on diagnosis and treatment of allergic diseases to be presented at the ACAAI meeting

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

HAE patients have prodromal symptoms that signal an oncoming HAE attack, reports survey

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

Evaluation of DX-88 to resolve symptoms of acute HAE attacks to be presented

Interim data from Schering-Plough's narlaprevir Phase IIa study

Interim data from Schering-Plough's narlaprevir Phase IIa study

Schering-Plough receives FDA complete response letter regarding PEGINTRON

Schering-Plough receives FDA complete response letter regarding PEGINTRON